Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
FF Rahaghi, VM Hsu, RJ Kaner, MD Mayes… - Respiratory …, 2023 - Springer
Abstract Background Systemic sclerosis (SSc) is a rare, complex, connective tissue disorder.
Interstitial lung disease (ILD) is common in SSc, occurring in 35–52% of patients and …
Interstitial lung disease (ILD) is common in SSc, occurring in 35–52% of patients and …
[HTML][HTML] British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
CS Haworth, J Banks, T Capstick, AJ Fisher, T Gorsuch… - Thorax, 2017 - thorax.bmj.com
Background Since the publication of the British Thoracic Society (BTS) Guideline on the
'Management of opportunistic mycobacterial infections' in 2000, our understanding of the …
'Management of opportunistic mycobacterial infections' in 2000, our understanding of the …
The therapy of idiopathic pulmonary fibrosis: what is next?
V Somogyi, N Chaudhuri, SE Torrisi… - European …, 2019 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease, characterised by progressive scarring of the lung and associated with a high …
disease, characterised by progressive scarring of the lung and associated with a high …
Systemic sclerosis–associated interstitial lung disease: How to incorporate two food and drug administration–approved therapies in clinical practice
Systemic sclerosis (SSc; scleroderma) has the highest individual mortality of all rheumatic
diseases, and interstitial lung disease (ILD) is among the leading causes of SSc‐related …
diseases, and interstitial lung disease (ILD) is among the leading causes of SSc‐related …
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
V Cottin, KK Brown - Respiratory research, 2019 - Springer
Abstract Background Systemic sclerosis (SSc) is a rare connective tissue disease with a
heterogeneous clinical course. Interstitial lung disease (ILD) is a common manifestation of …
heterogeneous clinical course. Interstitial lung disease (ILD) is a common manifestation of …
Six-minute walk test: clinical role, technique, coding, and reimbursement
P Agarwala, SH Salzman - Chest, 2020 - Elsevier
The 6-min walk test (6MWT) is a commonly used test for the objective assessment of
functional exercise capacity for the management of patients with moderate-to-severe …
functional exercise capacity for the management of patients with moderate-to-severe …
Global, race-neutral reference equations and pulmonary function test interpretation
Importance Race and ethnicity are routinely used to inform pulmonary function test (PFT)
interpretation. However, there is no biological justification for such use, and it may reinforce …
interpretation. However, there is no biological justification for such use, and it may reinforce …
Lung transplantation for idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis.
Lung transplantation is the only intervention shown to increase life expectancy for patients …
Lung transplantation is the only intervention shown to increase life expectancy for patients …
Immunotherapies for COVID-19: lessons learned from sepsis
KE Remy, SC Brakenridge, B Francois… - The Lancet …, 2020 - thelancet.com
Therapeutic approaches to mitigate the severe acute lung injury associated with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have rapidly entered …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have rapidly entered …
Chronic obstructive pulmonary disease: evaluation and management
SP Duffy, GJ Criner - Medical Clinics, 2019 - medical.theclinics.com
As the third leading cause of death in the United States in 2014, chronic obstructive
pulmonary disease (COPD) presents a significant challenge to the health care provider. 1 …
pulmonary disease (COPD) presents a significant challenge to the health care provider. 1 …